{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:34:17Z","timestamp":1793446457772,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["137011"],"award-info":[{"award-number":["137011"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2R01CA143167"],"award-info":[{"award-number":["2R01CA143167"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00401-019-02111-y","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T09:02:52Z","timestamp":1575882172000},"page":"223-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study"],"prefix":"10.1007","volume":"139","author":[{"given":"Bryan K.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vasiljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fupan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben L. B.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene I.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Gururangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Hansford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Fouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumihito","family":"Nobusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Laquerriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Bernadette","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Fangusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma","family":"Solano-Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Birks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Szathmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Faure-Conter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Catchpoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris Ann P.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gauchotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Jabado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Loussouarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ashley","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"2111_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76 (Chapter 7:Unit7)","journal-title":"Curr Protoc Hum Genet"},{"key":"2111_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","volume":"6","author":"J An","year":"2014","unstructured":"An J, Wang C, Deng Y, Yu L, Huang H (2014) Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants. Cell Rep 6:657\u2013669. https:\/\/doi.org\/10.1016\/j.celrep.2014.01.013","journal-title":"Cell Rep"},{"key":"2111_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.4135","volume":"229","author":"MS Anglesio","year":"2013","unstructured":"Anglesio MS, Wang Y, Yang W, Senz J, Wan A, Heravi-Moussavi A et al (2013) Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol 229:400\u2013409. https:\/\/doi.org\/10.1002\/path.4135","journal-title":"J Pathol"},{"key":"2111_CR4","first-page":"1691","volume":"3","author":"A Baldi","year":"1997","unstructured":"Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG et al (1997) Differential expression of Rb2\/p130 and p107 in normal human tissues and in primary lung cancer. Clin Cancer Res 3:1691\u20131697","journal-title":"Clin Cancer Res"},{"key":"2111_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP et al (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 44:685\u2013689. https:\/\/doi.org\/10.1038\/ng.2279","journal-title":"Nat Genet"},{"key":"2111_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0360-3016(94)90560-6","volume":"29","author":"LE Blach","year":"1994","unstructured":"Blach LE, McCormick B, Abramson DH, Ellsworth RM (1994) Trilateral retinoblastoma\u2014incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys 29:729\u2013733","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR7","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1074\/jbc.M112.437996","volume":"288","author":"P Canning","year":"2013","unstructured":"Canning P, Cooper CD, Krojer T, Murray JW, Pike AC, Chaikuad A et al (2013) Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. J Biol Chem 288:7803\u20137814. https:\/\/doi.org\/10.1074\/jbc.M112.437996","journal-title":"J Biol Chem"},{"key":"2111_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"2111_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm972","volume":"10","author":"CD Chen","year":"2004","unstructured":"Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33\u201339. https:\/\/doi.org\/10.1038\/nm972","journal-title":"Nat Med"},{"key":"2111_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fonc.2016.00113","volume":"6","author":"HY Chen","year":"2016","unstructured":"Chen HY, Chen RH (2016) Cullin 3 ubiquitin ligases in cancer biology: functions and therapeutic implications. Front Oncol 6:113. https:\/\/doi.org\/10.3389\/fonc.2016.00113","journal-title":"Front Oncol"},{"key":"2111_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1215\/15228517-2008-079","volume":"11","author":"M Chintagumpala","year":"2009","unstructured":"Chintagumpala M, Hassall T, Palmer S, Ashley D, Wallace D, Kasow K et al (2009) A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol 11:33\u201340. https:\/\/doi.org\/10.1215\/15228517-2008-079","journal-title":"Neuro Oncol"},{"key":"2111_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1101\/gad.17027411","volume":"25","author":"K Conkrite","year":"2011","unstructured":"Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM et al (2011) miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 25:1734\u20131745. https:\/\/doi.org\/10.1101\/gad.17027411","journal-title":"Genes Dev"},{"key":"2111_CR13","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/1078-0432.ccr-03-0524","volume":"10","author":"G D'Andrilli","year":"2004","unstructured":"D'Andrilli G, Masciullo V, Bagella L, Tonini T, Minimo C, Zannoni GF et al (2004) Frequent loss of pRb2\/p130 in human ovarian carcinoma. Clin Cancer Res 10:3098\u20133103. https:\/\/doi.org\/10.1158\/1078-0432.ccr-03-0524","journal-title":"Clin Cancer Res"},{"key":"2111_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","volume":"15","author":"MC de Jong","year":"2014","unstructured":"de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivel\u00e4 T, Moll AC (2014) Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 15:1157\u20131167. https:\/\/doi.org\/10.1016\/S1470-2045(14)70336-5","journal-title":"Lancet Oncol"},{"key":"2111_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128:583\u2013595. https:\/\/doi.org\/10.1007\/s00401-014-1318-7","journal-title":"Acta Neuropathol"},{"key":"2111_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccr.2012.04.023","volume":"21","author":"C De Vito","year":"2012","unstructured":"De Vito C, Riggi N, Cornaz S, Suva ML, Baumer K, Provero P et al (2012) A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell 21:807\u2013821. https:\/\/doi.org\/10.1016\/j.ccr.2012.04.023","journal-title":"Cancer Cell"},{"key":"2111_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.wneu.2014.07.010","volume":"82","author":"B Farnia","year":"2014","unstructured":"Farnia B, Allen PK, Brown PD, Khatua S, Levine NB, Li J et al (2014) Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review. World Neurosurg 82:1232\u20131241. https:\/\/doi.org\/10.1016\/j.wneu.2014.07.010","journal-title":"World Neurosurg"},{"key":"2111_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2990.2011.01202.x","volume":"38","author":"M Fevre-Montange","year":"2012","unstructured":"Fevre-Montange M, Vasiljevic A, Frappaz D, Champier J, Szathmari A, Aubriot Lorton MH et al (2012) Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study. Neuropathol Appl Neurobiol 38:87\u201394. https:\/\/doi.org\/10.1111\/j.1365-2990.2011.01202.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2111_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrc3802","volume":"14","author":"WD Foulkes","year":"2014","unstructured":"Foulkes WD, Priest JR, Duchaine TF (2014) DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer 14:662\u2013672. https:\/\/doi.org\/10.1038\/nrc3802","journal-title":"Nat Rev Cancer"},{"key":"2111_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/neuonc\/nos292","volume":"15","author":"C Friedrich","year":"2013","unstructured":"Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F et al (2013) Treatment of young children with CNS-primitive neuroectodermal tumors\/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 15:224\u2013234. https:\/\/doi.org\/10.1093\/neuonc\/nos292","journal-title":"Neuro Oncol"},{"key":"2111_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ng1010-817","volume":"42","author":"P Garre","year":"2010","unstructured":"Garre P, Perez-Segura P, Diaz-Rubio E, Caldes T, de la Hoya M (2010) Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Nat Genet 42:817\u2013818. https:\/\/doi.org\/10.1038\/ng1010-817","journal-title":"Nat Genet"},{"key":"2111_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozretic L, Kong G et al (2015) Comprehensive genomic profiles of small cell lung cancer. Nature 524:47\u201353. https:\/\/doi.org\/10.1038\/nature14664","journal-title":"Nature"},{"key":"2111_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-008-9589-2","volume":"89","author":"SW Gilheeney","year":"2008","unstructured":"Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L et al (2008) Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol 89:89\u201395. https:\/\/doi.org\/10.1007\/s11060-008-9589-2","journal-title":"J Neurooncol"},{"key":"2111_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1054\/jocn.2000.0829","volume":"8","author":"M Gonzales","year":"2001","unstructured":"Gonzales M (2001) The 2000 World Health Organization classification of tumours of the nervous system. J Clin Neurosci 8:1\u20133. https:\/\/doi.org\/10.1054\/jocn.2000.0829","journal-title":"J Clin Neurosci"},{"key":"2111_CR25","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1200\/JCO.2005.01.2799","volume":"23","author":"PE Grundy","year":"2005","unstructured":"Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML et al (2005) Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312\u20137321. https:\/\/doi.org\/10.1200\/JCO.2005.01.2799","journal-title":"J Clin Oncol"},{"key":"2111_CR26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1261\/rna.032680.112","volume":"18","author":"AM Gurtan","year":"2012","unstructured":"Gurtan AM, Lu V, Bhutkar A, Sharp PA (2012) In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA 18:1116\u20131122. https:\/\/doi.org\/10.1261\/rna.032680.112","journal-title":"RNA"},{"key":"2111_CR27","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1200\/JCO.2003.10.096","volume":"21","author":"S Gururangan","year":"2003","unstructured":"Gururangan S, McLaughlin C, Quinn J, Rich J, Reardon D, Halperin EC et al (2003) High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 21:2187\u20132191. https:\/\/doi.org\/10.1200\/JCO.2003.10.096","journal-title":"J Clin Oncol"},{"key":"2111_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1056\/NEJMoa1102903","volume":"366","author":"A Heravi-Moussavi","year":"2012","unstructured":"Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L et al (2012) Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 366:234\u2013242. https:\/\/doi.org\/10.1056\/NEJMoa1102903","journal-title":"N Engl J Med"},{"key":"2111_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.4720","author":"EI Hwang","year":"2018","unstructured":"Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S et al (2018) Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children's Oncology Group Randomized ACNS0332 trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2017.76.4720","journal-title":"J Clin Oncol"},{"key":"2111_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.25405","volume":"62","author":"RI Jakacki","year":"2015","unstructured":"Jakacki RI, Burger PC, Kocak M, Boyett JM, Goldwein J, Mehta M et al (2015) Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 62:776\u2013783. https:\/\/doi.org\/10.1002\/pbc.25405","journal-title":"Pediatr Blood Cancer"},{"key":"2111_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1200\/JCO.1995.13.6.1377","volume":"13","author":"RI Jakacki","year":"1995","unstructured":"Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR et al (1995) Survival and prognostic factors following radiation and\/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol 13:1377\u20131383. https:\/\/doi.org\/10.1200\/JCO.1995.13.6.1377","journal-title":"J Clin Oncol"},{"key":"2111_CR32","first-page":"170","volume-title":"WHO classification of tumours of the central nervous system","author":"A Jouvet","year":"2016","unstructured":"Jouvet A, Vasiljevic A, Nakazato Y, Tanaka S (2016) Tumours of the pineal region. In: Louis D (ed) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, France, pp 170\u2013182","edition":"4"},{"key":"2111_CR33","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1101\/gad.1848209","volume":"23","author":"MS Kumar","year":"2009","unstructured":"Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J et al (2009) Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23:2700\u20132704. https:\/\/doi.org\/10.1101\/gad.1848209","journal-title":"Genes Dev"},{"key":"2111_CR34","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/ajmg.a.38474","volume":"176","author":"MP Lambert","year":"2018","unstructured":"Lambert MP, Arulselvan A, Schott A, Markham SJ, Crowley TB, Zackai EH et al (2018) The 22q11.2 deletion syndrome: cancer predisposition, platelet abnormalities and cytopenias. Am J Med Genet A 176:2121\u20132127. https:\/\/doi.org\/10.1002\/ajmg.a.38474","journal-title":"Am J Med Genet A"},{"key":"2111_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-01990-5","author":"JC Lee","year":"2019","unstructured":"Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-01990-5","journal-title":"Acta Neuropathol"},{"key":"2111_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ccr.2014.06.014","volume":"26","author":"Y Li","year":"2014","unstructured":"Li Y, Choi PS, Casey SC, Dill DL, Felsher DW (2014) MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell 26:262\u2013272. https:\/\/doi.org\/10.1016\/j.ccr.2014.06.014","journal-title":"Cancer Cell"},{"key":"2111_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15:321\u2013333. https:\/\/doi.org\/10.1038\/nrc3932","journal-title":"Nat Rev Cancer"},{"key":"2111_CR38","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1158\/1541-7786.MCR-13-0131","volume":"11","author":"Z Liu","year":"2013","unstructured":"Liu Z, Gersbach E, Zhang X, Xu X, Dong R, Lee P et al (2013) miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma. Mol Cancer Res 11:1314\u20131325. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0131","journal-title":"Mol Cancer Res"},{"key":"2111_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1086\/514845","volume":"61","author":"DR Lohmann","year":"1997","unstructured":"Lohmann DR, Gerick M, Brandt B, Oelschlager U, Lorenz B, Passarge E et al (1997) Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet 61:282\u2013294. https:\/\/doi.org\/10.1086\/514845","journal-title":"Am J Hum Genet"},{"key":"2111_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ijrobp.2005.09.026","volume":"64","author":"M Massimino","year":"2006","unstructured":"Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F et al (2006) Supratentorial primitive neuroectodermal tumors (S-PNET) in children: a prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Int J Radiat Oncol Biol Phys 64:1031\u20131037. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.09.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR41","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12:R41. https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41","journal-title":"Genome Biol"},{"key":"2111_CR42","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/neuonc\/nor070","volume":"13","author":"S Miller","year":"2011","unstructured":"Miller S, Rogers HA, Lyon P, Rand V, Adamowicz-Brice M, Clifford SC et al (2011) Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma. Neuro Oncol 13:866\u2013879. https:\/\/doi.org\/10.1093\/neuonc\/nor070","journal-title":"Neuro Oncol"},{"key":"2111_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4%3c515::AID-IJC9%3e3.0.CO;2-V","volume":"67","author":"AC Moll","year":"1996","unstructured":"Moll AC, Imhof SM, Bouter LM, Kuik DJ, Den Otter W, Bezemer PD et al (1996) Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945\u20131994. Int J Cancer 67:515\u2013519. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19960807)67:4%3c515:AID-IJC9%3e3.0.CO;2-V","journal-title":"Int J Cancer"},{"key":"2111_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gcc.20176","volume":"43","author":"SK Mummert","year":"2005","unstructured":"Mummert SK, Lobanenkov VA, Feinberg AP (2005) Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Genes Chromosomes Cancer 43:155\u2013161. https:\/\/doi.org\/10.1002\/gcc.20176","journal-title":"Genes Chromosomes Cancer"},{"key":"2111_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/neuonc\/now234","volume":"19","author":"M Mynarek","year":"2017","unstructured":"Mynarek M, Pizer B, Dufour C, van Vuurden D, Garami M, Massimino M et al (2017) Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro Oncol 19:576\u2013585. https:\/\/doi.org\/10.1093\/neuonc\/now234","journal-title":"Neuro Oncol"},{"key":"2111_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226434","author":"L Nguyen","year":"2018","unstructured":"Nguyen L, Crawford JR (2018) Pineosblastoma in a child with 22q11.2 deletion syndrome. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-226434","journal-title":"BMJ Case Rep"},{"key":"2111_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ncb2556","volume":"14","author":"D Nittner","year":"2012","unstructured":"Nittner D, Lambertz I, Clermont F, Mestdagh P, Kohler C, Nielsen SJ et al (2012) Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation. Nat Cell Biol 14:958\u2013965. https:\/\/doi.org\/10.1038\/ncb2556","journal-title":"Nat Cell Biol"},{"key":"2111_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311\u2013317. https:\/\/doi.org\/10.1038\/nature22973","journal-title":"Nature"},{"key":"2111_CR49","doi-asserted-by":"publisher","first-page":"66467","DOI":"10.18632\/oncotarget.20191","volume":"8","author":"Z Pan","year":"2017","unstructured":"Pan Z, He H, Tang L, Bu Q, Cheng H, Wang A et al (2017) Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms\u2019 tumor: a meta-analysis. Oncotarget 8:66467\u201366475. https:\/\/doi.org\/10.18632\/oncotarget.20191","journal-title":"Oncotarget"},{"key":"2111_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/neuros\/nyx005","volume":"81","author":"KA Parikh","year":"2017","unstructured":"Parikh KA, Venable GT, Orr BA, Choudhri AF, Boop FA, Gajjar AJ et al (2017) Pineoblastoma\u2014the experience at St. Jude Children's Research Hospital. Neurosurgery 81:120\u2013128. https:\/\/doi.org\/10.1093\/neuros\/nyx005","journal-title":"Neurosurgery"},{"key":"2111_CR51","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4161\/cbt.8.8.7921","volume":"8","author":"K Priya","year":"2009","unstructured":"Priya K, Jada SR, Quah BL, Quah TC, Lai PS (2009) High incidence of allelic loss at 16q12.2 region spanning RBL2\/p130 gene in retinoblastoma. Cancer Biol Ther 8:714\u2013717. https:\/\/doi.org\/10.4161\/cbt.8.8.7921","journal-title":"Cancer Biol Ther"},{"key":"2111_CR52","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1038\/onc.2014.150","volume":"33","author":"TJ Pugh","year":"2014","unstructured":"Pugh TJ, Yu W, Yang J, Field AL, Ambrogio L, Carter SL et al (2014) Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene 33:5295\u20135302. https:\/\/doi.org\/10.1038\/onc.2014.150","journal-title":"Oncogene"},{"key":"2111_CR53","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1038\/ncomms5802","volume":"2","author":"D Rakheja","year":"2014","unstructured":"Rakheja D, Chen KS, Liu Y, Shukla AA, Schmid V, Chang TC et al (2014) Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours. Nat Commun 2:4802. https:\/\/doi.org\/10.1038\/ncomms5802","journal-title":"Nat Commun"},{"key":"2111_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/neuonc\/nou357","volume":"18","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Adamski J, Bartels U, Tabori U, Wang X et al (2016) Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro Oncol 18:291\u2013297. https:\/\/doi.org\/10.1093\/neuonc\/nou357","journal-title":"Neuro Oncol"},{"key":"2111_CR55","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1200\/JCO.2017.72.7842","volume":"35","author":"V Ramaswamy","year":"2017","unstructured":"Ramaswamy V, Taylor MD (2017) Medulloblastoma: from myth to molecular. J Clin Oncol 35:2355\u20132363. https:\/\/doi.org\/10.1200\/JCO.2017.72.7842","journal-title":"J Clin Oncol"},{"key":"2111_CR56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-08-1892","volume":"69","author":"R Saab","year":"2009","unstructured":"Saab R, Rodriguez-Galindo C, Matmati K, Rehg JE, Baumer SH, Khoury JD et al (2009) p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. Cancer Res 69:440\u2013448. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1892","journal-title":"Cancer Res"},{"key":"2111_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmedgenet-2012-100898","volume":"49","author":"N Sabbaghian","year":"2012","unstructured":"Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49:417\u2013419. https:\/\/doi.org\/10.1136\/jmedgenet-2012-100898","journal-title":"J Med Genet"},{"key":"2111_CR58","unstructured":"SEER Cancer Statistics Review 1975\u20132015, Table 29.1 (2019) https:\/\/seer.cancer.gov\/csr\/1975_2015\/browse_csr.php. Accessed 1 July 2019"},{"key":"2111_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccell.2019.06.002","volume":"36","author":"P Sin-Chan","year":"2019","unstructured":"Sin-Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I et al (2019) A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor. Cancer Cell 36:51\u201367.e57. https:\/\/doi.org\/10.1016\/j.ccell.2019.06.002","journal-title":"Cancer Cell"},{"key":"2111_CR60","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41467-018-05029-3","volume":"9","author":"M Snuderl","year":"2018","unstructured":"Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J et al (2018) Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nat Commun 9:2868. https:\/\/doi.org\/10.1038\/s41467-018-05029-3","journal-title":"Nat Commun"},{"key":"2111_CR61","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ccr3.880","volume":"5","author":"T Stevens","year":"2017","unstructured":"Stevens T, Van der Werff Ten Bosch J, De Rademaeker M, Van Den Bogaert A, van den Akker M (2017) Risk of malignancy in 22q11.2 deletion syndrome. Clin Case Rep 5:486\u2013490. https:\/\/doi.org\/10.1002\/ccr3.880","journal-title":"Clin Case Rep"},{"key":"2111_CR62","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/hupa.2001.23514","volume":"32","author":"T Susini","year":"2001","unstructured":"Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A et al (2001) Expression of the retinoblastoma-related gene Rb2\/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol 32:360\u2013367. https:\/\/doi.org\/10.1053\/hupa.2001.23514","journal-title":"Hum Pathol"},{"key":"2111_CR63","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.2005.04.8074","volume":"24","author":"B Timmermann","year":"2006","unstructured":"Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Meisner C, Pietsch T et al (2006) Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol 24:1554\u20131560. https:\/\/doi.org\/10.1200\/JCO.2005.04.8074","journal-title":"J Clin Oncol"},{"key":"2111_CR64","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ccell.2016.11.003","volume":"30","author":"J Torchia","year":"2016","unstructured":"Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A et al (2016) Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30:891\u2013908. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.003","journal-title":"Cancer Cell"},{"key":"2111_CR65","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1038\/ncomms5039","volume":"5","author":"GT Torrezan","year":"2014","unstructured":"Torrezan GT, Ferreira EN, Nakahata AM, Barros BD, Castro MT, Correa BR et al (2014) Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour. Nat Commun 5:4039. https:\/\/doi.org\/10.1038\/ncomms5039","journal-title":"Nat Commun"},{"key":"2111_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nprot.2015.123","volume":"11","author":"R Vaser","year":"2016","unstructured":"Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11:1\u20139. https:\/\/doi.org\/10.1038\/nprot.2015.123","journal-title":"Nat Protoc"},{"key":"2111_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2015.01.003","volume":"27","author":"AL Walz","year":"2015","unstructured":"Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM et al (2015) Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell 27:286\u2013297. https:\/\/doi.org\/10.1016\/j.ccell.2015.01.003","journal-title":"Cancer Cell"},{"key":"2111_CR68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ccell.2015.01.002","volume":"27","author":"J Wegert","year":"2015","unstructured":"Wegert J, Ishaque N, Vardapour R, Georg C, Gu Z, Bieg M et al (2015) Mutations in the SIX1\/2 pathway and the DROSHA\/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell 27:298\u2013311. https:\/\/doi.org\/10.1016\/j.ccell.2015.01.002","journal-title":"Cancer Cell"},{"key":"2111_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2017.09.044","volume":"412","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Gu J, Li Y, Peng C, Shi M, Wang X et al (2018) MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2\/E2F4-repressing complexes. Cancer Lett 412:59\u201368. https:\/\/doi.org\/10.1016\/j.canlet.2017.09.044","journal-title":"Cancer Lett"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02111-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:35:52Z","timestamp":1607387752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02111-y","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}